Microbot Medical Secures Lovell Deal to Place LIBERTY System in Over 2,000 Federal Facilities
MBOT•Microbot Medical partnered with Lovell Government Services to add its LIBERTY® Endovascular Robotic System to Lovell’s Federal Supply Schedule for more than 2,000 Veterans Affairs, Defense and Indian Health Service sites. Activation in Q3 2026 with GSA Advantage, DLA ECAT and DoD DAPA listings simplifies procurement and meets SDVOSB goals.
1. Partnership Agreement
Microbot Medical has entered into a service agreement with Lovell Government Services, designated as a Service-Disabled Veteran-Owned Small Business vendor, to introduce the LIBERTY® Endovascular Robotic System into federal healthcare systems. The partnership targets the Veterans Health Administration, Military Health System and Indian Health Service networks via federal contracting channels.
2. Federal Supply Schedule Inclusion
Under the deal, the LIBERTY System will be added to Lovell’s Federal Supply Schedule contract, with activation slated for the third quarter of 2026. This inclusion offers a streamlined procurement route for over 2,000 medical centers and outpatient clinics across federal agencies.
3. Additional Procurement Channels
Beyond the FSS listing, the system will be accessible through GSA Advantage, the Defense Logistics Agency’s Electronic Catalog and the Department of Defense’s Distribution and Pricing Agreement. These platforms expand the addressable market and simplify ordering for federal buyers.
4. Strategic Implications
The agreement aligns with Microbot Medical’s commercial strategy by providing a clear, SDVOSB-compliant procurement pathway and leveraging Lovell’s four-time Inc. 5000 track record. This federal expansion is expected to accelerate awareness and adoption of the LIBERTY System among veteran, active-duty and Native American patient populations.
